TNBC patients treated with neoadjuvant chemotherapy and PD-1 checkpoint inhibition with a pCR expressed higher PD-L1 expression on both tumor cells and macrophages compared to patients with a non-pCR [86]. Here, CD274 is linked to neoplasm.